Citius Pharmaceuticals, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q4 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Citius Pharmaceuticals, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q4 2010 to Q2 2024.
  • Citius Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$10.6M, a 24.7% decline year-over-year.
  • Citius Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$38.3M, a 25.2% decline year-over-year.
  • Citius Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$32.5M, a 3.26% increase from 2022.
  • Citius Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$33.6M, a 45.9% decline from 2021.
  • Citius Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$23.1M, a 31.4% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$38.3M -$10.6M -$2.09M -24.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 -$36.2M -$8.54M +$1.98M +18.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 -$38.2M -$9.23M -$5.64M -157% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-14
Q3 2023 -$32.5M -$9.94M -$1.95M -24.4% Jul 1, 2023 Sep 30, 2023 10-K 2023-12-29
Q2 2023 -$30.6M -$8.48M +$384K +4.34% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 -$31M -$10.5M -$2.96M -39.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 -$28M -$3.59M +$5.63M +61% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-14
Q3 2022 -$33.6M -$7.99M -$3.03M -61.1% Jul 1, 2022 Sep 30, 2022 10-K 2023-12-29
Q2 2022 -$30.6M -$8.86M -$3.04M -52.2% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-11
Q1 2022 -$27.6M -$7.56M -$3.44M -83.4% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-12
Q4 2021 -$24.1M -$9.23M -$1.08M -13.2% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-10
Q3 2021 -$23.1M -$4.96M -$840K -20.4% Jul 1, 2021 Sep 30, 2021 10-K 2022-12-22
Q2 2021 -$22.2M -$5.82M -$1.14M -24.4% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$21.1M -$4.12M +$303K +6.84% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 -$21.4M -$8.15M -$3.82M -88.5% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-10
Q3 2020 -$17.5M -$4.12M -$471K -12.9% Jul 1, 2020 Sep 30, 2020 10-K 2021-12-15
Q2 2020 -$17.1M -$4.68M -$275K -6.23% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$16.8M -$4.42M -$793K -21.8% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q4 2019 -$16M -$4.32M -$448K -11.6% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-11
Q3 2019 -$15.6M -$3.65M -$803K -28.2% Jul 1, 2019 Sep 30, 2019 10-K 2020-12-16
Q2 2019 -$14.8M -$4.41M -$2.38M -118% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 -$12.4M -$3.63M +$790K +17.9% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-14
Q4 2018 -$13.2M -$3.87M -$629K -19.4% Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-13
Q3 2018 -$12.5M -$2.85M +$196K +6.45% Jul 1, 2018 Sep 30, 2018 10-K 2019-12-16
Q2 2018 -$12.7M -$2.02M +$401K +16.5% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 -$13.1M -$4.42M -$1.68M -61.2% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 -$11.5M -$3.25M -$1.07M -49.2% Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-14
Q3 2017 -$10.4M -$3.04M -$454K -17.5% Jul 1, 2017 Sep 30, 2017 10-K 2019-12-16
Q2 2017 -$9.93M -$2.42M +$1.19M +33% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 -$11.1M -$2.74M -$1.87M -216% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-11
Q4 2016 -$9.25M -$2.18M -$955K -78.2% Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-14
Q3 2016 -$8.3M -$2.59M -$1.68M -185% Jul 1, 2016 Sep 30, 2016 10-K 2018-12-11
Q2 2016 -$6.61M -$3.62M -$2.79M -338% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 -$3.82M -$869K -$524K -152% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 -$3.3M -$1.22M -$397K -48.2% Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-14
Q3 2015 -$2.9M -$908K -$830K -1062% Jul 1, 2015 Sep 30, 2015 10-K 2017-12-13
Q2 2015 -$2.07M -$825K -$790K -2265% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-15
Q1 2015 -$1.28M -$345K -$255K -282% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-20
Q4 2014 -$1.03M -$824K -$289K -54.1% Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-12
Q3 2014 -$738K -$78.2K Jul 1, 2014 Sep 30, 2014 10-K 2016-12-23
Q2 2014 -$34.9K -$30.4K Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-13
Q1 2014 -$90.3K -$80.1K -783% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-13
Q4 2013 -$534K -$533K Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-17
Q2 2013 -$4.43K* +$2.4K Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-14
Q1 2013 -$10.2K -$3.02K -41.9% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-15
Q4 2012 -$1.42K* +$1.15K Oct 1, 2012 Dec 31, 2012 10-Q 2014-02-19
Q2 2012 -$19.4K -$6.84K* +$479 Apr 1, 2012 Jun 30, 2012 10-Q 2013-09-18
Q1 2012 -$19.9K -$7.21K +$50.00 +0.69% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-13
Q4 2011 -$19.9K -$2.57K* +$6.44K Oct 1, 2011 Dec 31, 2011 10-Q 2013-02-08
Q3 2011 -$26.3K -$2.76K Jul 1, 2011 Sep 30, 2011 10-Q 2014-05-15
Q2 2011 -$7.32K Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-17
Q1 2011 -$7.26K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-11
Q4 2010 -$9.01K Oct 1, 2010 Dec 31, 2010 10-Q 2012-02-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.